ARCA biopharma (ABIO) Institutional Ownership $3.14 +0.07 (+2.28%) (As of 07/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for ARCA biopharma (NASDAQ:ABIO)CurrentInstitutional OwnershipPercentage56.44%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$6.86MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$26.53K Get ABIO Insider Trade Alerts Want to know when executives and insiders are buying or selling ARCA biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ABIO Institutional Buying and Selling by Quarter Ad Weiss RatingsNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. ARCA biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/20/2024Cable Car Capital LLC4,000,452$6.80M7.6%N/A27.589% 1/31/2024abrdn plc32,461$55K0.0%N/A0.000% 11/14/2023Newtyn Management LLC300,000$603K0.1%-4.2%0.000% 4/14/2023BML Capital Management LLC706,930$1.41M1.2%-17.6%0.000% 2/13/2023BML Capital Management LLC858,256$2.03M1.9%N/A5.956% 2/10/2023Murchinson Ltd.50,593$120K0.0%N/A0.351% Get the Latest News and Ratings for ABIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter. 11/7/2022Virtu Financial LLC14,221$29K0.0%N/A0.099% 7/27/2022 Bailard Inc.35,000$87K0.0%N/A0.243% 4/26/2022Marquette Asset Management LLC17,318$40K0.0%N/A0.120% 2/10/2022Acadian Asset Management LLC57,822$123K0.0%N/A0.401% 11/15/2021GSA Capital Partners LLP441,945$1.31M0.1%+238.9%3.067% 11/15/2021Minerva Advisors LLC10,000$30K0.0%N/A0.069% 11/9/2021BlackRock Inc.268,394$795K0.0%-1.8%1.863% 8/16/2021State Street Corp69,037$241K0.0%N/A0.479% 8/13/2021Geode Capital Management LLC87,659$305K0.0%+10.7%0.608% 8/13/2021Vanguard Group Inc.398,507$1.39M0.0%+189.8%2.765% 8/12/2021XTX Topco Ltd10,846$38K0.0%N/A0.075% 8/5/2021GSA Capital Partners LLP130,395$455K0.1%+39.8%0.905% 5/19/2021Virtu Financial LLC16,655$61K0.0%-32.4%0.116% 5/17/2021PDT Partners LLC17,297$63K0.0%N/A0.120% 5/12/2021Geode Capital Management LLC79,151$288K0.0%+141.7%0.549% 5/10/2021GSA Capital Partners LLP93,241$340K0.1%+102.3%0.647% 2/24/2021Virtu Financial LLC24,641$99K0.0%N/A0.264% 2/10/2021Renaissance Technologies LLC205,500$824K0.0%+436.4%2.205% 2/10/2021Panagora Asset Management Inc.6,878$28K0.0%N/A0.074% 2/4/2021GSA Capital Partners LLP46,097$185K0.0%N/A0.495% 11/19/2020Schonfeld Strategic Advisors LLC18,200$80K0.0%N/A0.195% 11/17/2020Schonfeld Strategic Advisors LLC18,200$80K0.0%N/A0.195% 11/6/2020BlackRock Inc.287,263$1.27M0.0%+598,364.6%4.865% 8/13/2020Tekla Capital Management LLC32,461$215K0.0%-10.0%0.550% (Data available from 1/1/2016 forward) ABIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ABIO shares? During the previous two years, the following institutional investors and hedge funds held shares of ARCA biopharma shares: Cable Car Capital LLC ($6.80M), BML Capital Management LLC ($1.41M), Newtyn Management LLC ($603K), Murchinson Ltd. ($120K), Bailard Inc. ($87K), and abrdn plc ($55K), and Virtu Financial LLC ($29K).Learn more on ABIO's institutional investors. What percentage of ARCA biopharma stock is owned by institutional investors? 56.44% of ARCA biopharma stock is owned by institutional investors. Learn more on ABIO's institutional investor holdings. Which institutional investors have been buying ARCA biopharma stock? The following institutional investors have purchased ARCA biopharma stock in the last 24 months: Cable Car Capital LLC ($4.00M), BML Capital Management LLC ($858.26K), Murchinson Ltd. ($50.59K), Bailard Inc. ($35K), abrdn plc ($32.46K), and Virtu Financial LLC ($14.22K). How much institutional buying is happening at ARCA biopharma? Institutional investors have bought a total of 4,990,983 shares in the last 24 months. This purchase volume represents approximately $9.13M in transactions. Which ARCA biopharma major shareholders have been selling company stock? The following institutional investors have sold ARCA biopharma stock in the last 24 months: BML Capital Management LLC ($151.33K), and Newtyn Management LLC ($13.20K). How much institutional selling is happening at ARCA biopharma? Institutional investors have sold a total of 164,526 shares in the last 24 months. This volume of shares sold represents approximately $327.67K in transactions. Related Companies: Achieve Life Sciences Major Shareholders Alpha Teknova Major Shareholders VolitionRx Major Shareholders ImmuCell Major Shareholders OncoCyte Major Shareholders Trinity Biotech Major Shareholders Aspira Women's Health Major Shareholders Cardio Diagnostics Major Shareholders Biomerica Major Shareholders MyMD Pharmaceuticals Major Shareholders This page (NASDAQ:ABIO) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARCA biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ARCA biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.